CCL3 and lung carcinoma: Although the data demonstrate that exposure of healthy donor PBMCs to lung cancer cell lines increases CCL3, IL8 and IL1β production by CD3+ and CD14+ PBMC fractions, it remains unclear as to the specific interaction which causes this result.